Previous close | 13.77 |
Open | 13.84 |
Bid | 13.81 x 100 |
Ask | 13.90 x 100 |
Day's range | 13.68 - 13.97 |
52-week range | 6.70 - 18.00 |
Volume | |
Avg. volume | 194,933 |
Market cap | 3.88B |
Beta (5Y monthly) | -0.02 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.08 |
Earnings date | 27 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 19.00 |
REYKJAVIK, Iceland, May 29, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Healthcare Conference in New York on June 5-6, 2024. Alvotech will present and host investor and business meetings at the conference. Anil Okay, Chief Business Officer, is scheduled to give a presentation at the conference on June 6, 2024, at 1:00 pm
Alvotech ( NASDAQ:ALVO ) shareholders will have a reason to smile today, with the analysts making substantial upgrades...
Alvotech ( NASDAQ:ALVO ) First Quarter 2024 Results Key Financial Results Revenue: US$36.9m (up 132% from 1Q 2023). Net...